Going into 2026, biotech company Ladder Bio is embracing a new identity.
Zacks Investment Research on MSN
ANIP vs. TEVA: Which drug stock is the better buy right now?
Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and ...
AbbVie has signed a landmark US administration deal, pledging $100bn in domestic manufacturing and R&D investment in exchange ...
AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback